Investors in London-listed medical tech firm continue battle to oust top brass BUSINESS Investors in a London-listed medical technology firm are continuing their campaign to oust the company’s top brass as its share price languishes.
US regulator accepts GSK’s application to expand treatment of cancer drug pharma The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.